Bon Secours reported operating revenues of $2.5 billion in the nine months ended May 31, up 2.4 percent from the same period a year earlier. The growth was driven by higher ambulatory patient volumes, managed care rate increases and revenue cycle improvements, Bon Secours said in recently released financial disclosures.
The system said expenses climbed 3.5 percent year over year. Bon Secours attributed the increase to several factors, including continued expansion of physician practices, higher pharmaceutical costs and transitioning its home care unit to an Epic EHR system.
Bon Secours ended the nine-month period with operating income of $58.8 million, down 28.5 percent from $81.3 million in the comparable period of the year prior.
After accounting for investment gains of $74.6 million, the system ended the nine-month period with net income of $105.1 million, more than triple the net income of $33.8 million it reported in the same period of the year prior.
More articles on healthcare finance:
CMS releases OPPS proposed rule for 2018: 10 things to know
Louisiana specialty hospital to close less than 4 years after opening
Child’s $21M medical bill underscores Medi-Cal challenges
Editor’s note: This article was updated July 20. A previous version misstated Bon Secours operating income.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
